Halozyme Therapeutics Inc (HALO)
39.91
+0.09
(+0.23%)
USD |
NASDAQ |
May 03, 16:00
39.92
+0.01
(+0.03%)
After-Hours: 20:00
Halozyme Therapeutics Debt to Equity Ratio: 17.89 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 17.89 |
| September 30, 2023 | 6.010 |
| June 30, 2023 | 9.905 |
| March 31, 2023 | 22.69 |
| December 31, 2022 | 8.87 |
| September 30, 2022 | 15.51 |
| June 30, 2022 | 4.251 |
| March 31, 2022 | 3.372 |
| December 31, 2021 | 4.451 |
| September 30, 2021 | 3.109 |
| June 30, 2021 | 7.305 |
| March 31, 2021 | 12.93 |
| December 31, 2020 | 2.630 |
| September 30, 2020 | 3.977 |
| June 30, 2020 | 3.695 |
| March 31, 2020 | 6.710 |
| December 31, 2019 | 4.387 |
| September 30, 2019 | 0.2602 |
| June 30, 2019 | 0.3267 |
| March 31, 2019 | 0.4053 |
| December 31, 2018 | 0.5078 |
| September 30, 2018 | 0.6109 |
| June 30, 2018 | 0.6513 |
| March 31, 2018 | 0.6985 |
| December 31, 2017 | 0.9711 |
| Date | Value |
|---|---|
| September 30, 2017 | 2.858 |
| June 30, 2017 | 3.628 |
| March 31, 2017 | -3.659 |
| December 31, 2016 | -6.669 |
| September 30, 2016 | -17.69 |
| June 30, 2016 | 20.98 |
| March 31, 2016 | 6.651 |
| December 31, 2015 | 1.159 |
| September 30, 2015 | 1.566 |
| June 30, 2015 | 0.9905 |
| March 31, 2015 | 1.324 |
| December 31, 2014 | 1.206 |
| September 30, 2014 | 1.248 |
| June 30, 2014 | 0.9008 |
| March 31, 2014 | 0.746 |
| December 31, 2013 | -2.490 |
| September 30, 2013 | -8.534 |
| June 30, 2013 | 2.667 |
| March 31, 2013 | 0.937 |
| December 31, 2012 | 0.6072 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.2602
Minimum
Sep 2019
22.69
Maximum
Mar 2023
7.278
Average
4.451
Median
Dec 2021
Debt to Equity Ratio Benchmarks
| Novavax Inc | -0.2344 |
| Globus Medical Inc | 0.1044 |
| Denali Therapeutics Inc | -- |
| AIM ImmunoTech Inc | 0.00 |
| Protalix BioTherapeutics Inc | 0.6033 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.733B |
| Total Liabilities (Quarterly) | 1.649B |
| Shareholders Equity (Quarterly) | 83.81M |
| Current Ratio | 6.635 |
| Net Debt Paydown Yield | 0.02% |